Martin LF, Kem WR and FreedmanR (2004). Alpha-7 Nicotinic Receptor Agonists: Potential New Candidates for the Treatment of Schizophrenia. Psychopharmacology 174: 54-64. 
Harris JG, Kongs S, Allensworth D, Martin LF, Tregellas J, Sullivan B, Zerbe G and Freedman R (2004). Effects of Nicotine on Cognitive Deficits in Schizophrenia. Neuropsychopharmacology 29: 1378-1385.
Olincy A and Martin L (2005). Failure to inhibit the P50 auditory evoked potential in bipolar subjects with a history of psychosis. American Journal of Psychiatry 162 (1): 43-9.
Freedman R, Ross RG, Leonard S, Worsley M, Adams C, Waldo M, Tregellas J, Martin L, Olincy A, Tanabe J, Kisley M, Hunter S and Stevens K (2005). Early Biomarkers of Psychosis. Dialogues in Clinical Neuroscience 7(1): 17-29.
Ann Olincy; Josette G. Harris; Lynn L. Johnson; Vicki Pender; Susan Kongs; Diana Allensworth; Jamey Ellis; Gary O. Zerbe; Sherry Leonard; Karen E. Stevens; James O. Stevens; Laura Martin; Lawrence E. Adler; Ferenc Soti; William R. Kem; Robert Freedman (2006). Proof-of-Concept Trial of an  7 Nicotinic Agonist in Schizophrenia. Arch Gen Psychiatry 63: 630-638.
Martin LF and Freedman R (2007). Schizophrenia and the alpha7 Nicotinic Acetylcholine Receptor. International Rev Neurobiol. 78:225-46.
Martin LF, Hall MH, Leonard S, Olincy A, Tregellas J, Freedman R (2007). Sensory Gating and Alpha-7 Nicotinic Receptor Gene Allelic Variants in Schizoaffective Disorder, Bipolar Type. Am J Med Genet B Neuropsychiatr Genet. Jul 5;144(5):611-4.
Martin LF, Hall MH, Ross RG, Zerbe G, Freedman R, Olincy A (2007). Physiology of Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder. Am J Psychiatry. 164(12):1900-6.
|
